Safety concerns for one in three US drugs

Safety concerns for one in three US drugsAlmost one in three newly approved drugs in the United States turns out to have a safety issue after it is allowed on the market, US researchers said Tuesday. While these issues are rarely serious enough to get the drug pulled from the marketplace, researchers said new drugs should be monitored for years after they are released to the public. Cutting-edge therapies known as biologics, psychiatric drugs, and medicines that were fast-tracked by the US Food and Drug Administration were most likely to require additional safety warnings after approval, said the report in Journal of the American Medical Association (JAMA).

Yahoo News – Latest News & Headlines